Regulatory Trends in AI-enabled SaMDs
FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…
FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…
Healthcare artificial intelligence (AI) has moved well beyond the experimental. It is already accelerating research, improving patient journeys and supporting diagnostics. The next wave, driven…
Lately, there has been a lot of talk about the potential use cases for—and benefits of—artificial intelligence (AI) for the pharmaceutical industry. Compared with other…
The promise of AI in healthcare is immense – but rushing to adopt it without addressing decades of fragmented data and disconnected systems risks amplifying…
Healthcare is deploying AI faster than it is defining what AI means. That distinction is not semantic – it is a patient safety question. The…
For years, cybersecurity in healthcare has been framed through a lens that depicts ransomware disrupting hospitals, data breaches exposing patient records and overstretched IT teams…
Workforce shortages and growing administrative pressure are placing increasing strain on the NHS, prompting managers to look for practical ways to support overstretched clinicians. According…
Shared Care Records (SCRs) have undergone significant evolution over the past two decades. What began as relatively simple mechanisms for sharing documents across organisational boundaries…
I’ve spent years working alongside my NHS clinical colleagues and operational leaders, and one theme is constant: documentation takes too much time and, with that,…
“The doctor will see you now.” Except this ‘doctor’ doesn’t wear a white coat or require patients to book an appointment. It’s available 24/7, ready…